Off-label use of ondansetron in pregnancy in Western Australia.

about

Studies using Australia's Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013).

P2860

Q30921563-3321DAAE-0132-40C4-BF34-08726C99C53E

P2860

Off-label use of ondansetron in pregnancy in Western Australia.

Item

http://www.wikidata.org/entity/Q42773009

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Off-label use of ondansetron in pregnancy in Western Australia.

@en

Off-label use of ondansetron in pregnancy in Western Australia.

@nl

type

Item

label

Off-label use of ondansetron in pregnancy in Western Australia.

@en

Off-label use of ondansetron in pregnancy in Western Australia.

@nl

prefLabel

Off-label use of ondansetron in pregnancy in Western Australia.

@en

Off-label use of ondansetron in pregnancy in Western Australia.

@nl

P1476

Off-label use of ondansetron in pregnancy in Western Australia

@en

P2093

Andrew W Gill

http://www.w3.org/2001/XMLSchema#string

Carol Bower

http://www.w3.org/2001/XMLSchema#string

Fiona J Stanley

http://www.w3.org/2001/XMLSchema#string

P2860

Motherisk update. Is ondansetron safe for use during pregnancy?

Optimal fetal growth for the Caucasian singleton and assessment of appropriateness of fetal growth: an analysis of a total population perinatal database

Ascertainment of birth defects: the effect on completeness of adding a new source of data.

Choosing the best estimate of gestational age from routinely collected population-based perinatal data.

A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system.

Ondansetron in pregnancy and risk of adverse fetal outcomes.

Off-label use of medicines: consensus recommendations for evaluating appropriateness.

Hyperemesis gravidarum.

Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.

Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran)

P304

909860

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/909860

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Lyn Colvin

Linda Slack-Smith

P577

2013-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259608978

http://www.w3.org/2001/XMLSchema#string

P698

24396830

http://www.w3.org/2001/XMLSchema#string

P921

Australia

P932

3874333

http://www.w3.org/2001/XMLSchema#string

Off-label use of ondansetron in pregnancy in Western Australia.

about

P2860

P2860

Off-label use of ondansetron in pregnancy in Western Australia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P921

P932